About Affimed (AFMD)
Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research t... Read more
- USD4.15
- USD4.17
- USD4.00
- USD8.95
- 1.00%
- 3M
- 24.00
- 70.88k
- 61M
- 2.24
- -19.40%
Stock News
4 hours ago
Japan’s Icom says it hasn’t sold walkie-talkies that exploded in Lebanon in a decade
MarketWatch
4 hours ago
DA Davidson Names Meta Platforms, Inc. (META) a Top Mega-Cap Pick
Yahoo
4 hours ago
Broadcom Inc. (AVGO): Benchmark Recommends Buy Despite Tepid AI Momentum
Yahoo
4 hours ago
Palantir Technologies Inc. (PLTR) Secures Multi-Year AI Contract with Nebraska Medicine to Revolutionize Healthcare Operations
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
